Correction: Update of the European consensus on sarcopenia: what has changed in diagnosis and prevalence in peritoneal dialysis?

Abstract

Since publication of the original article the authors noticed two author names were displayed incorrectly. Maryanne Zilli Canedo da Silva should be Maryanne Zilli Canedo Silva, and Nayrana Soares do Carmo Reis should be Nayrana Soares Carmo Reis. Furthermore, since publication of the original article an erratum regarding the European consensus on sarcopenia was published [1]. This affected the original article's results in several ways. The results affected are listed below. Abstract "The prevalence of sarcopenia ranged from 4 to 10% according to cut points and references used" should read "The prevalence of sarcopenia remained 4% according to cut points and references used." Materials and methods Diagnosis of sarcopenia "Values below 7 kg/m² for men and 6 kg/m² for women were considered as decreased muscle mass and confirmation of the presence of sarcopenia [3]" should read "Values below 7 kg/m² for men and 5.5 kg/m² for women were considered as decreased muscle mass and confirmation of the presence of sarcopenia [3]." Results Table 1 was not affected by the change in results and is reproduced here: "Prevalence of sarcopenia according to the 2019 EWGSOP criteria was 10% (n = 5). Reduced muscle mass alone was prevalent in 20% (n = 10) and reduced muscle function assessed by HGS was frequent in 28% (n = 14)" should read "Prevalence of sarcopenia according to the 2019 EWGSOP criteria was 4% (n = 2). Reduced muscle mass alone was prevalent in 10% (n = 5) and reduced muscle function assessed by HGS was frequent in 28% (n = 14)." Figure 1 was affected by the change in results. Both the original Fig. 1 and updated Fig. 1 are produced below: Fig. 1 Prevalence of isolated reduced muscle mass and muscle function, and sarcopenia in PD patients (original).% 0 5 10 15 20 25 30 35 40 45 R Redu uced d mu uscle E e ma EWG ass GSOP P, 20 Red 010 duce fun ed m ncƟo EW musc on WGSO cle OP, 2019 9 Sa arcop peni ia Fig. 1 Prevalence of isolated reduced muscle mass and muscle function, and sarcopenia in PD patients (updated) DiscussionThe original article can be found online at https://doi.org/10.1038/ s41430-019-0468-z. 1234567890();,: 1234567890();,:

Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis

“…The characteristics of the included studies are summarized in Table 1. The 30 13,14,22–49 studies enrolled 6162 individuals who were included in the qualitative analysis. All of the included studies were published after 2013.…”

“…However, this merged result was lacking robustness caused by the high heterogeneity and small sample size of some studies among the included literature. For example, in two included articles that both diagnosed sarcopenia by combined criteria (LMM plus LMS and/or LPP), one reported the prevalence of sarcopenia in dialysis as 4%, 13 while the value in the other was 68%, 14 and both only involved 50 cases. The random‐effects model was applied in response to the high heterogeneity between the studies; however, the differences between the two groups became statistically significant when we implemented the fixed‐effects model, and this further proved that the merged result was not satisfactorily robust and the conclusion lacked reliability.…”

“…Future intervention researches for sarcopenia in dialysis patients need an accurate estimate of prevalence. However, the prevalence of sarcopenia is affected by the large variability in diagnostic criteria and characteristics of patients and varies too widely (4 13 –68% 14 ) to use for comparison. Therefore, we performed this review to provide a comprehensive picture of the diagnostic criteria and prevalence of sarcopenia in those treated by dialysis and interpret its predictive value in terms of overall mortality.…”